Novel Corona virus (COVID-19)
Corona contagions are positive sense single stranded RNA contagions that beget infection in nose, sinuses, or upper throat. It belongs to family of SARS and MERS. COVID-19 is the illness caused by SARS-COV-2, first outbreak does Wuhan megacity in China.
The pathogenesis of COVID-19 isn't defined but reports from numerous countries indicate that the contagion has the same medium by which it enters or invades host cells as SARS-COV. The origin of SARS-CoV-2 isn't well- established, still, it's established that batons are the fountainhead of affiliated contagions and that mortal to mortal transmission plays a critical part in its pathogenesis After entering into target cells following Shaft protein association with its receptor, viral RNA is reprised and polyadenylated, and encodes colorful structural andnon-structural polypeptide genes.
These polyproteins are adhered by proteases that parade chymotrypsin-suchlike exertion. Although transmembrane serine protease 2 (TMPRSS2) is the major protease associated with CoV activation and has been linked to SARS-CoV-2 activation, recent substantiation from single cell RNA-sequencing (scRNA-seq) analysis shows that ACE2 and TMPRSS2 aren't expressed in the same cell suggesting the involvement of other proteases similar as cathepsin B and L in this process.
In general, pattern recognition receptors (PRRs) fete overrunning pathogens including contagion’s. Contagions evoke several crucial host vulnerable responses similar as adding the release of seditious factors, induction and development of dendritic cells (DCs) and adding the conflation of type I interferons (IFNs), which are important in limiting viral spread. Both the ingrain and acquired vulnerable response is actuated by SARS-CoV-2. CD4 T cells stimulate B cells to produce contagion-specific antibodies including immunoglobulin (Ig) G and IgM and CD8 T cells directly kill contagion-infected cells. T coadjutor cells producer-inflammatory cytokines and intercessors to help the other vulnerable cells. SARS-CoV-2 can block the host vulnerable defense by suppressing T cell functions by converting their programmed cell deathe.g., by apoptosis. Likewise, the host product of complement factors similar as C3a and C5a and antibodies are critical in combating the viral infection.
Related Conference of Novel Corona virus (COVID-19)
3rd International Conference on Immunology & Immunotherapies
17th International Conference on Allergy and Clinical Immunology
International summit on Immunotherapeutic Strategies Against Pathogens
Novel Corona virus (COVID-19) Conference Speakers
Recommended Sessions
- Diagnostic Immunology
- Haematopoietic, Lymphoid Malignancies and Immune System Development
- Immune System and Immunology
- Immunization and Vaccination
- Veterinary Allergology
- Allergy and Immunology
- Autoimmune Diseases and HIV
- Immune Disorder
- Immune Response Regulation
- Immunogenetics
- Immunoresearch and Immunotechnology
- Microbial Parasitic and Fungal Immunology
- Mucosal and regional Immunology
- Neonatal and Pediatric Immunology
- NeuroImmunology
- Novel Corona virus (COVID-19)
- OncoImmunology
- Stem Cells Immunology
- Technological Innovations in Immunology
- Therapeutic approaches to autoimmunity
- Thyroid Autoimmunity
- Transplantation and Computational Immunology
- Vaccines and Immunotherapy
- Veterinary and Comparative Immunology
- Viral Immunology
Related Journals
Are you interested in
- Allergy Medicine and Alternatives - ALLERGY 2022 (Singapore)
- Allergy, Hypersensitivity and Asthma - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Antibody Therapies - Immunotherapeutics-2022 (France)
- Antimicrobial drugs - EURO INFECTIOUS CONGRESS (Germany)
- Asthma and COPD - ALLERGY 2022 (Singapore)
- Auto immune - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Autoimmunity and Allergies - Immunotherapeutics-2022 (France)
- Cancer Vaccines - VACCINE CONGRESS 2022 (UK)
- Cellular Immunology and Latest Innovations - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Chicken pox Vaccines - VACCINE CONGRESS 2022 (UK)
- Childhood Vaccines - VACCINE CONGRESS 2022 (UK)
- Clinical Immunology & Current & Future Research - Neuroimmunology Congress 2022 (Italy)
- Clinical Immunology and Allergy - ALLERGY 2022 (Singapore)
- Clinical Immunology: Current & Future Research - Immunotherapeutics-2022 (France)
- Clinical Immunology: Current & Future Research - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Clinical Infectious Diseases - EURO INFECTIOUS CONGRESS (Germany)
- Communicable & Non-Communicable Diseases - Neuroimmunology Congress 2022 (Italy)
- Component Vaccines - VACCINE CONGRESS 2022 (UK)
- Coronaviruses (COVID-19) - Neuroimmunology Congress 2022 (Italy)
- Covid-19 - EURO INFECTIOUS CONGRESS (Germany)
- COVID-19 and Immunodeficiency - ALLERGY 2022 (Singapore)
- COVID-19 Vaccine - VACCINE CONGRESS 2022 (UK)
- Diagnosis of Infection - Neuroimmunology Congress 2022 (Italy)
- Diagnostic And Technological Novelty Of Immunology - Immunotherapeutics-2022 (France)
- Diagnostic And Technological Novelty Of Immunology - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Diagnostic Immunology - ALLERGY 2022 (Singapore)
- Diarrhoeal diseases - EURO INFECTIOUS CONGRESS (Germany)
- Discovery of Antibiotics - Neuroimmunology Congress 2022 (Italy)
- Discovery of Antibiotics - Immunotherapeutics-2022 (France)
- Diseases caused by virus - EURO INFECTIOUS CONGRESS (Germany)
- DNA Vaccines - WORLD VACCINE MEET 2022 (Japan)
- Ebola Vaccines - VACCINE CONGRESS 2022 (UK)
- Epidemiology & Transmission - EURO INFECTIOUS CONGRESS (Germany)
- Food Allergies and Infections - ALLERGY 2022 (Singapore)
- Food Pathology - EURO INFECTIOUS CONGRESS (Germany)
- Future of Food Allergy - ALLERGY 2022 (Singapore)
- Genetics Immunology & Vaccinology - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Haematopoietic And Lymphoid Malignancies And Immune System Development - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Herpes simplex virus - EURO INFECTIOUS CONGRESS (Germany)
- HIV Vaccines - VACCINE CONGRESS 2022 (UK)
- HPV and RV Vaccines - WORLD VACCINE MEET 2022 (Japan)
- HPV infections - EURO INFECTIOUS CONGRESS (Germany)
- Human Papilloma Virus Vaccine - VACCINE CONGRESS 2022 (UK)
- Immune Deficiency - Immunotherapeutics-2022 (France)
- Immune Disorders - Neuroimmunology Congress 2022 (Italy)
- Immune regulation - WORLD VACCINE MEET 2022 (Japan)
- Immuno-Genetics - Neuroimmunology Congress 2022 (Italy)
- Immuno-informatics - WORLD VACCINE MEET 2022 (Japan)
- Immunogenetics and immune tolerance - WORLD VACCINE MEET 2022 (Japan)
- Immunohistochemistry - Immunotherapeutics-2022 (France)
- Immunologic Techniques, Microbial Control and Therapeutics - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Immunological Clinical Practices &Trials - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Immunology and its future research - WORLD VACCINE MEET 2022 (Japan)
- Immunotherapy - Immunotherapeutics-2022 (France)
- Immunotherapy and Transplantation - ALLERGY 2022 (Singapore)
- Immunotherapy and Transplantation - Immunotherapeutics-2022 (France)
- Infection and cancer - EURO INFECTIOUS CONGRESS (Germany)
- Infection and Immunity - ALLERGY 2022 (Singapore)
- Infections with immunodeficiencies - EURO INFECTIOUS CONGRESS (Germany)
- Infectious disease - VACCINE CONGRESS 2022 (UK)
- Infectious Diseases - Neuroimmunology Congress 2022 (Italy)
- Infectious Diseases, Emerging and Reemerging diseases: Confronting Future Outbreaks - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Inflammation and immuno therapies - WORLD VACCINE MEET 2022 (Japan)
- Innate Immune Responses - Neuroimmunology Congress 2022 (Italy)
- Market and Future of Therapeutics - ALLERGY 2022 (Singapore)
- Market and Future of Therapeutics - Immunotherapeutics-2022 (France)
- MMR Vaccines - VACCINE CONGRESS 2022 (UK)
- Molecular and Cellular Mechanisms of Allergic Diseases - ALLERGY 2022 (Singapore)
- Molecular diagnosis of infectious diseases - EURO INFECTIOUS CONGRESS (Germany)
- Neonatal and Pediatric Immunology - ALLERGY 2022 (Singapore)
- Neuro immunology - Immunotherapeutics-2022 (France)
- Neuroimmunology - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Neuroimmunology - Neuroimmunology Congress 2022 (Italy)
- Neurological infections - EURO INFECTIOUS CONGRESS (Germany)
- Novel Corona virus (COVID-19) - WORLD VACCINE MEET 2022 (Japan)
- Nutritional Immunology: - Immunotherapeutics-2022 (France)
- Ocular Immunology & Inflammation - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Paediatric and Neonatal Immunology - Neuroimmunology Congress 2022 (Italy)
- Pediatric Immunology - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Pneumonia - EURO INFECTIOUS CONGRESS (Germany)
- Polio Vaccines - VACCINE CONGRESS 2022 (UK)
- Preclinical and Clinical Safety of DNA Vaccines - WORLD VACCINE MEET 2022 (Japan)
- Preclinical Vaccine Studies - VACCINE CONGRESS 2022 (UK)
- Problems in Infectious Disease practice - Neuroimmunology Congress 2022 (Italy)
- Recombinant Vector Vaccines - VACCINE CONGRESS 2022 (UK)
- Respiratory and Pulmonary Infectious Diseases - Neuroimmunology Congress 2022 (Italy)
- Scope of Infectious Diseases - EURO INFECTIOUS CONGRESS (Germany)
- Skin Allergy and Inflammations - ALLERGY 2022 (Singapore)
- social behaviour on infectious diseases - EURO INFECTIOUS CONGRESS (Germany)
- Tuberculosis (TB) - EURO INFECTIOUS CONGRESS (Germany)
- Tuberculosis Vaccines - VACCINE CONGRESS 2022 (UK)
- Vaccine Adjuvants - VACCINE CONGRESS 2022 (UK)
- Vaccine Bioprocess and Manufacturing - WORLD VACCINE MEET 2022 (Japan)
- Vaccine Regulatory Issues - VACCINE CONGRESS 2022 (UK)
- Vaccine Research & Development - VACCINE CONGRESS 2022 (UK)
- Vaccine research and development - WORLD VACCINE MEET 2022 (Japan)
- Vaccine Safety and efficacy - WORLD VACCINE MEET 2022 (Japan)
- Vaccine Technology - WORLD VACCINE MEET 2022 (Japan)
- Vaccines - EURO INFECTIOUS CONGRESS (Germany)
- Vaccines & Immunization - Neuroimmunology Congress 2022 (Italy)
- Vaccines and Immunization - ALLERGY 2022 (Singapore)
- Vaccines and Vaccinology - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Vaccines and Vaccinology - Immunotherapeutics-2022 (France)
- Vaccines Dermatology - VACCINE CONGRESS 2022 (UK)
- Vaccines Epidemiology - VACCINE CONGRESS 2022 (UK)
- Vaccines for Immune Mediated Diseases - IMMUNOLOGY & IMMUNOTHERAPIES 2022 (Singapore)
- Vaccines for Immune-Mediated Diseases - Immunotherapeutics-2022 (France)
- Vaccines Immunology - VACCINE CONGRESS 2022 (UK)
- Veterinary Vaccines - VACCINE CONGRESS 2022 (UK)
- Virology and infectious diseases - Neuroimmunology Congress 2022 (Italy)
- Virology and infectious diseases - Immunotherapeutics-2022 (France)